Literature DB >> 12391357

High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit.

I Parviainen1, A Uusaro, R Kälviäinen, E Kaukanen, E Mervaala, E Ruokonen.   

Abstract

The authors studied prospectively the effects of thiopental anesthesia on seizure control, hemodynamics, and the course of intensive care in 10 patients with refractory status epilepticus. Clinical and electrophysiological seizures were terminated in every patient. Hemodynamically, thiopental was well tolerated, but slow recovery from anesthesia prolonged the need for intensive care.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12391357     DOI： 10.1212/01.wnl.0000032253.88378.d7

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  20 in total

1.  Treatment of refractory status epilepticus in childhood.

Authors:  John M Schreiber; William D Gaillard
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

2.  A randomized trial for the treatment of refractory status epilepticus.

Authors:  Andrea O Rossetti; Tracey A Milligan; Serge Vulliémoz; Costas Michaelides; Manuel Bertschi; Jong Woo Lee
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

3.  Propofol in the treatment of refractory status epilepticus.

Authors:  Ilkka Parviainen; Ari Uusaro; Reetta Kälviäinen; Esa Mervaala; Esko Ruokonen
Journal:  Intensive Care Med       Date:  2006-05-06       Impact factor: 17.440

4.  Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety.

Authors:  Flavio Bellante; Benjamin Legros; Chantal Depondt; Jacques Créteur; Fabio Silvio Taccone; Nicolas Gaspard
Journal:  J Neurol       Date:  2016-02-25       Impact factor: 4.849

Review 5.  What's new in refractory status epilepticus?

Authors:  Stephane Legriel; Mauro Oddo; Gretchen M Brophy
Journal:  Intensive Care Med       Date:  2016-08-20       Impact factor: 17.440

Review 6.  Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults.

Authors:  Martin Holtkamp
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

Review 7.  Refractory generalised convulsive status epilepticus : a guide to treatment.

Authors:  Reetta Kälviäinen; Kai Eriksson; Ilkka Parviainen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

8.  Propylene glycol toxicity complicating use of barbiturate coma.

Authors:  Kathleen A Bledsoe; Andreas H Kramer
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

9.  Analysis of the delay components in the treatment of status epilepticus.

Authors:  Leena Kämppi; Harri Mustonen; Seppo Soinila
Journal:  Neurocrit Care       Date:  2013-08       Impact factor: 3.210

10.  Bowel ischemia: a rare complication of thiopental treatment for status epilepticus.

Authors:  Carlo Cereda; Mette M Berger; Andrea O Rossetti
Journal:  Neurocrit Care       Date:  2008-11-25       Impact factor: 3.210
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.